Polish Clinical Trials Market Reaches New Heights

  • Home
  • Newsroom
  • Polish Clinical Trials Market Reaches New Heights
Polish Clinical Trials Market Reaches New Heights - Axcellant

Polish Clinical Trials Market Reaches New Heights

  1. Aug 20, 2024

Over the past two decades, the Polish CRO industry has transformed dramatically. What began with simple monitoring tasks has evolved into comprehensive offerings, covering full-process management, data analysis, and early-phase trials.

Today, the value of clinical trials in Poland stands at approximately €1.5 billion, contributing to an overall European market of around €12 billion, which is growing steadily at a rate of 5–6% year-on-year.

Thanks to private investments and robust scientific infrastructure, Poland and the CEE region have established a compelling position in global clinical research. Their emergence is a story of rapid evolution—from a supportive environment into a true innovation hub.

Marcel Zatoński (Puls Biznesu) helped highlight this transformation in a recent article. Don’t miss the full story: read the piece here (in Polish).

Resources

Axcellant appointed Global CRO for Santersus’ multinational pivotal study in sepsis

Axcellant, a specialist global contract research organization (CRO), has been appointed by Switzerland-based Santersus AG to support the execution of…

Axcellant to Attend EANM 2026 in Vienna

Axcellant will participate in the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), taking place from 17…

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…